LIFE : Summary for aTyr Pharma, Inc. - Yahoo Finance

U.S. Markets closed

aTyr Pharma, Inc. (LIFE)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.45-0.05 (-2.00%)
At close: 4:00PM EST
People also watch
QGENILMNPKIXRAYNWSA
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close2.50
Open2.50
Bid2.20 x 1500
Ask3.80 x 300
Day's Range2.45 - 2.58
52 Week Range2.10 - 6.81
Volume156,733
Avg. Volume169,296
Market Cap58.11M
BetaN/A
PE Ratio (TTM)-0.98
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Associated Press13 days ago

    Roberts recuses from patent case after discovering conflict

    Supreme Court Chief Justice John Roberts says he will no longer participate in deciding a patent infringement case because he discovered he owns shares in the parent company of one of the parties. Roberts ...

  • GuruFocus.com27 days ago

    Atyr Pharma Inc (LIFE) CEO and Director John Mendlein Bought $151,800 of Shares

    CEO and Director of Atyr Pharma Inc (NASDAQ:LIFE) John Mendlein bought 69,000 shares of LIFE on 12/19/2016 at an average price of $2.2 a share.

  • Does aTyr Pharma Inc (LIFE) Stack Up Against Its Peers?
    Insider Monkeylast month

    Does aTyr Pharma Inc (LIFE) Stack Up Against Its Peers?

    A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors can look at the overall hedge fund sentiment towards the stocks included in their watchlists. These freshly-submitted public filings disclose money managers’ equity positions as of the end of the three-month period […]